Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:GLEO

Galileo Acquisition (GLEO) Stock Price, News & Analysis

Galileo Acquisition logo

About Galileo Acquisition Stock (NYSE:GLEO)

Key Stats

Today's Range
N/A
50-Day Range
$7.24
$10.64
52-Week Range
N/A
Volume
N/A
Average Volume
115,273 shs
Market Capitalization
$3,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Galileo Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on companies operating in the consumer, retail, food and beverage, fashion and luxury, specialty industrial, technology or healthcare sectors. Galileo Acquisition Corp. was incorporated in 2019 and is based in New York, New York.

Receive GLEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galileo Acquisition and its competitors with MarketBeat's FREE daily newsletter.

GLEO Stock News Headlines

Shapeways Holdings, Inc. (SHPWQ)
Galileo High School
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet
If you missed out on Nvidia, watch this BEFORE November 19th.
Replay: Shapeways CEO in Fireside Chat
Join Shapeways CEO in Fireside Chat on Sept. 21 at 3PM EDT
See More Headlines

GLEO Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Galileo Acquisition investors own include Ceragon Networks (CRNT), LogicBio Therapeutics (LOGC), Avidity Biosciences (RNA), Adaptive Biotechnologies (ADPT), Precision BioSciences (DTIL), Homology Medicines (FIXX) and Gossamer Bio (GOSS).

Company Calendar

Today
11/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous Manufacturing Industries
Sub-Industry
N/A
Phone
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-1,530,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$3,000.00
Optionable
Not Optionable
Beta
0.15
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:GLEO) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners